InvestorsHub Logo
Followers 138
Posts 22908
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Friday, 09/11/2020 9:06:05 PM

Friday, September 11, 2020 9:06:05 PM

Post# of 298
The Oxford vaccine

Astrazeneca could screen out vaccine recipients for John Cunningham virus (JCV) prior to getting the vaccine.

London: Two days after the worrying news of the clinical trials of Oxford-AstraZeneca’s COVID vaccine candidate being halted, the drugmaker revealed that a participant had developed severe neurological symptoms.

It was found that a woman reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord. However, it has not been confirmed that it’s indeed transverse myelitis and more tests are being carried.



https://odishabytes.com/astrazeneca-reveals-why-its-covid-19-vaccine-was-halted/

JC Virus Induced Longitudinally Extensive Transverse Myelitis in Immunocompromised Patient



https://scholarlycommons.henryford.com/cgi/viewcontent.cgi?article=1057&context=merf2019caserpt

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AZN News